Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Abstract excerpt

BACKGROUND: Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and the association of genetically predicted IGF-I with aggressive prostate cancer is not known. We aimed to investigate the associations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to GDF15 and Related Biomarkers
• Share to Growth Hormone and Insulin-like Growth Factors
• Share to Prostate Cancer Diagnosis and Treatment